Nakagawa-Saito, Y.; Saitoh, S.; Mitobe, Y.; Sugai, A.; Togashi, K.; Suzuki, S.; Kitanaka, C.; Okada, M.
HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny. Int. J. Mol. Sci. 2022, 23, 8084.
https://doi.org/10.3390/ijms23158084
AMA Style
Nakagawa-Saito Y, Saitoh S, Mitobe Y, Sugai A, Togashi K, Suzuki S, Kitanaka C, Okada M.
HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny. International Journal of Molecular Sciences. 2022; 23(15):8084.
https://doi.org/10.3390/ijms23158084
Chicago/Turabian Style
Nakagawa-Saito, Yurika, Shinichi Saitoh, Yuta Mitobe, Asuka Sugai, Keita Togashi, Shuhei Suzuki, Chifumi Kitanaka, and Masashi Okada.
2022. "HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny" International Journal of Molecular Sciences 23, no. 15: 8084.
https://doi.org/10.3390/ijms23158084
APA Style
Nakagawa-Saito, Y., Saitoh, S., Mitobe, Y., Sugai, A., Togashi, K., Suzuki, S., Kitanaka, C., & Okada, M.
(2022). HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny. International Journal of Molecular Sciences, 23(15), 8084.
https://doi.org/10.3390/ijms23158084
